The imperative of influenza vaccines for elderly individuals-an evolving story
- PMID: 19508160
- PMCID: PMC2843138
- DOI: 10.1086/599791
The imperative of influenza vaccines for elderly individuals-an evolving story
Conflict of interest statement
Potential conflicts of interest: G.A.P. serves as an investigator for vaccine clinical studies funded by Wyeth and the National Institutes of Health (NIH). G.A.P. also serves as the chair of a safety evaluation committee for a novel influenza vaccine and other vaccines being developed by Merck Research Laboratories and offers consultative advice on new vaccine development to GlaxoSmithKline, Merck, Novartis, Novavax, Avianix, CSL Limited, and Spaldataq. M.J.M. directs NIH-funded clinical trials of influenza vaccines and adjuvants produced by sanofi pasteur and Novartis. He is an investigator for non-influenza vaccine trials funded by Merck and sanofi pasteur.
Comment on
-
Randomized, double-blind controlled phase 3 trial comparing the immunogenicity of high-dose and standard-dose influenza vaccine in adults 65 years of age and older.J Infect Dis. 2009 Jul 15;200(2):172-80. doi: 10.1086/599790. J Infect Dis. 2009. PMID: 19508159 Clinical Trial.
Similar articles
-
[The evaluation of the epidemiological efficacy of 3-component inactivated influenza vaccines using an intranasal application method].Zh Mikrobiol Epidemiol Immunobiol. 1993 Nov-Dec;(6):76-8. Zh Mikrobiol Epidemiol Immunobiol. 1993. PMID: 8079581 Russian. No abstract available.
-
Vaccine decisions loom for new flu strain.Nature. 2009 May 14;459(7244):144-5. doi: 10.1038/459144a. Nature. 2009. PMID: 19444174 No abstract available.
-
[Vaccine prophylaxis of influenza].Tr Inst Im Pastera. 1992;67:45-64. Tr Inst Im Pastera. 1992. PMID: 8539767 Review. Russian. No abstract available.
-
Complexities in assessing the effectiveness of inactivated influenza vaccines.Euro Surveill. 2013 Feb 14;18(7):1. Euro Surveill. 2013. PMID: 23449181 No abstract available.
-
[Prevention of influenza in the aged].Zh Mikrobiol Epidemiol Immunobiol. 1988 Sep;(9):93-6. Zh Mikrobiol Epidemiol Immunobiol. 1988. PMID: 3061266 Review. Russian. No abstract available.
Cited by
-
Transcriptomic signatures of cellular and humoral immune responses in older adults after seasonal influenza vaccination identified by data-driven clustering.Sci Rep. 2018 Jan 15;8(1):739. doi: 10.1038/s41598-017-17735-x. Sci Rep. 2018. PMID: 29335477 Free PMC article.
-
Utilizing population variation, vaccination, and systems biology to study human immunology.Trends Immunol. 2015 Aug;36(8):479-93. doi: 10.1016/j.it.2015.06.005. Epub 2015 Jul 14. Trends Immunol. 2015. PMID: 26187853 Free PMC article. Review.
-
Immunopotentiation of trivalent influenza vaccine when given with VAX102, a recombinant influenza M2e vaccine fused to the TLR5 ligand flagellin.PLoS One. 2010 Dec 28;5(12):e14442. doi: 10.1371/journal.pone.0014442. PLoS One. 2010. PMID: 21203437 Free PMC article. Clinical Trial.
References
-
- Thompson WW, Shay DK, Weintraub E, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003;289:179–86. - PubMed
-
- Molinari NA, Ortega-Sanchez IR, Messonnier ML, et al. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine. 2007;25:5086–96. - PubMed
-
- Vu T, Farish S, Jenkins M, Kelly H. A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community. Vaccine. 2002;20:1831–6. - PubMed
-
- Govaert TM, Thijs CT, Masurel N, Sprenger MJ, Dinant GJ, Knottnerus JA. The efficacy of influenza vaccination in elderly individuals: a randomized double-blind placebo-controlled trial. JAMA. 1994;272:1661–5. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- P30 AI050409/AI/NIAID NIH HHS/United States
- AI40065/AI/NIAID NIH HHS/United States
- AI33144/AI/NIAID NIH HHS/United States
- U19 AI057266/AI/NIAID NIH HHS/United States
- U01 AI069418/AI/NIAID NIH HHS/United States
- U19 AI057266-05S19002/AI/NIAID NIH HHS/United States
- AI69418/AI/NIAID NIH HHS/United States
- N01AI40065/AI/NIAID NIH HHS/United States
- R01 AI033144-15/AI/NIAID NIH HHS/United States
- R37 AI048793/AI/NIAID NIH HHS/United States
- FED200-2000-10062/PHS HHS/United States
- AI80005/AI/NIAID NIH HHS/United States
- P30 AI050409-09/AI/NIAID NIH HHS/United States
- AI57266/AI/NIAID NIH HHS/United States
- R01 AI033144/AI/NIAID NIH HHS/United States
- N01 AI040065/AI/NIAID NIH HHS/United States
- R01 AI048793/AI/NIAID NIH HHS/United States
- U01 AI069418-03/AI/NIAID NIH HHS/United States
- AI48793/AI/NIAID NIH HHS/United States
- R01 AI048793-09/AI/NIAID NIH HHS/United States
- UM1 AI069418/AI/NIAID NIH HHS/United States
- AI50409/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
